TFRC and cancer: Since cancer cells express more transferrin receptors than normal cells [69,70] and the activity of doxorubicin can be increased by ferrous iron in a Fenton-type reaction [71], doxorubicin–transferrin complexes have been considered to overcome drug resistance and induce ferroptosis as an iron-dependent mode of programmed cell death [72].